These results indicated that GLP-1RAs might play a useful role in the future treatment of PD
Endocrinology of gastric H+ and duodenal HCO3 secretion the role of grain-gut axis
The combination of slower emptying and bacterial shift explains why sulfur burps peak early in treatment and usually resolve on their own
The LifeMD Weight Management Program provides a personalized weight loss plan with professional support and, if approved, prescriptions for glucagon-like peptide-1 (GLP-1) medications
If you make a product that is a peptide that needs to go into an injection, thats a big manufacturing process, whereas if you made a small molecule that could be a tablet, thats something that could be scaled much faster, he explained
If passed, TROA would: Permanently allow Medicare Part D to cover FDA-approved anti-obesity medications Expand Medicare Part B coverage of intensive behavioral therapy for obesity to include a wider range of providers (not just primary care physicians) However, in April 2025, CMS announced it would not include Medicare Part D coverage of obesity drugs in its rule changes for 2026, stating the proposal was "not appropriate at this time." That decision pushed the issue back to Congress, where the TROA remains under consideration